Mount Sinai looking into long-term lung injury in Covid survivors

The Icahn School of Medicine at Mount Sinai on Thursday announced a collaboration with German pharmaceutical company Boehringer Ingelheim to study whether a drug could preserve the lung function of... To view the full story, click the title link.